Recent News

Upcoming Seminars and Events

View upcoming seminars and events.

Learn more
559 News Items found
Luis Parada in his lab
In the Lab
Why Do Brain Tumors Often Return After Treatment? MSK Researchers Say Stem Cells May Be Key

In a new study, MSK researchers looked at why glioblastoma brain tumors usually come back after treatment. Their findings suggest that a subset of cells — cancer stem cells — are able to evade current treatments because they are not actively dividing, and that these cells later form new tumors.
Separate headshots of three researchers — Diana Mandelker, Jorge Reis-Filho, and Fresia Pareja
Feature
How a Mishap in Early Development Can Lead to a Lifetime of Cancer Risk

MSK researchers have found mutations that arise in embryos can convey a risk of cancer that’s similar to what’s seen in people with inherited cancer mutations.
SKI scientists David Scheinberg and Derek Tan
Sloan Kettering Institute Scientists Retool CAR T Cells to Serve as ‘Micropharmacies’ for Cancer Drugs

These souped-up versions may help overcome some limitations of existing CAR T cells.
A scientist holding a tube in a lab
Sloan Kettering Institute Year in Review: 10 Noteworthy Science Breakthroughs of 2021

Take a look back at some of the biggest science stories from this past year.
Kalina Belcheva, Teddy Yewdell, Jayanta Chaudhuri, and Ryan Smolkin standing together in a lab
In the Lab
SKI Research Reveals New Insights into Immune Response to Viral Infections — Including COVID-19

Research from Sloan Kettering Institute immunologists suggests that the body may mount an immune response to respiratory viruses that lasts longer than previously thought. The discovery could impact the timing of COVID-19 vaccinations.
SKI immunologist Andrea Schietinger
Discovery of a Stem-like T Cell in Type 1 Diabetes Holds Potential for Improving Cancer Immunotherapy, Sloan Kettering Institute Scientists Say

As an autoimmune disease, Type 1 diabetes raises important questions about immune cell activity that have broad implications for immunotherapy.
Maria Jasin
In the Lab
Sloan Kettering Institute Researchers Discover One Way Genetic Mutations Occur During Formation of Eggs and Sperm

Investigators have employed mutant mice to study how the accumulation of genetic errors is managed during egg and sperm formation.
Memorial Sloan Kettering Cancer Center research technician Matthew Solowsky
From Navy Veteran to MSK Cancer Researcher: Matthew Solowsky’s Story

Meet Matthew Solowsky, a Navy veteran and Senior Research Technician in the Center for Molecular Oncology at Memorial Sloan Kettering Cancer Center.
Yonina Murciano-Goroff, Jenny Xue, Bob Li, Piro Lito, and Yulei Zhao.
Finding
MSK Researchers Are Learning Why Some Patients Develop Resistance to Targeted Lung Cancer Drug

A paper from MSK researchers reports that resistance to sotorasib, a new targeted drug for lung cancer, can be caused by many different molecular changes.
Paul Marks Prize 2021 winners
Twenty Years Of Honoring A Legacy: Three Investigators Named Winners of Memorial Sloan Kettering Cancer Center’s 2021 Paul Marks Prize for Cancer Research

Memorial Sloan Kettering Cancer Center (MSK) is proud to announce three innovative investigators as the recipients of this year’s Paul Marks Prize for Cancer Research.